SRAX Inc. (NASDAQ: SRAX) Set to Benefit as Analysts Hike Company’s Fourth Quarter Revenue Forecasts
Zacks Investment Research recently raised its forecast for SRAX’s 4Q21 revenues to $10.05mn, representing +122.3% YoY growth Zacks have also…
Blog
Amid Climate Change and National Food Security Concerns, PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Pursues Status as Plant-based Lifestyle Education Hub
PlantX Life Inc. is an e-commerce retailer devoted to not only selling plant products, but educating consumers about their effective…
BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Named as One of the Top 101 Food and Beverage Startups and Companies in Canada
Best Startup Canada named BevCanna Enterprises one of the 101 Top Food and Beverage Startups and Companies in Canada BevCanna…
QualityStocksNewsBreaks – LQwD Fintech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Releases Corporate and Operational Update
LQwD Fintech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning…
QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Releases Dates for 2022 Virtual Conferences
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS…
Sugarmade Inc.’s (SGMD) Nug Avenue Growth Fuels Expansion Plans
Nug Avenue success provides healthy backdrop as SGMD looks ahead to opening new locations In addition to adding members, Nug…
QualityStocksNewsBreaks – Friendable Inc. (FDBL) Issues 2021 Milestones, 2022 Strategy
Friendable (OTC: FDBL), a mobile technology and marketing company, has announced the expansion of service offerings available on its Fan Pass…
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Entering 2022 With Multiple Clinical Trials Including MYCO-001 for Smoking Cessation
Mydecine has partnered with Dr. Matthew Johnson and Johns Hopkins University for two upcoming trials for MYCO-001 – a psilocybin…
QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Annual Shareholder Letter Provides Company Highlights, 2022 Outlook
InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, has released a shareholder letter.…
QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces January 2022 Health Care Conference Schedule
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs,…